Sustained delivery of il-1ra from plga microspheres attenuates IL-1β mediated inflammation in a cartilage tissue analog  by Gorth, D.J. et al.
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S12112 weeks post-surgery. This increase in disease was not associated with
increased activity. In fact LABORAS revealed that female mice (at 2 weeks
post-surgery) spent more time running and climbing compared to their
male counterparts. Female mice developed painful behaviour at a similar
time post-surgery (12-14 weeks) to males, despite being at an earlier stage
of cartilage damage. We have recently described the molecular response to
acute joint destabilisation which reveals the mechanosensitive induction
of a number of inﬂammatory response genes and potential repair factors.
When we studied this panel of 47 genes in male and female joints we
found that some responded identically in male and female joints, whilst
other were more highly expressed in the female joints. Speciﬁcally, there
was no difference in the levels of Adamts5, IL1b or Mmp13, but TIMP1 (the
metalloproteinase inhibitor), inhibin (a TGFb family member), versican
and Mmp3 were signiﬁcantly higher in female joints.
Conclusions: Pre-menopausal female mice have signiﬁcantly less severe
OA compared to males, and this cannot be attributed to higher levels of
activity in male mice. Nor is it related to increased painful behaviour as
female mice have similar levels as male mice but with less cartilage
damage. The response to acute joint destabilisation reveals an increase in
predominantly matrix, repair and anti-inﬂammatory genes in female mice
compared to males, thereby suggesting that female mice may mount
a more anti-inﬂammatory/repair response compared to males.
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SUSTAINED DELIVERY OF IL-1RA FROM PLGA MICROSPHERES
ATTENUATES IL-1b MEDIATED INFLAMMATION IN A CARTILAGE
TISSUE ANALOG
D.J. Gorth, W. Strutz, B. Mohanraj, R.L. Mauck, L.J. Smith, G.R. Dodge. Univ.
of Pennsylvania, Philadelphia, PA, USA
Purpose: In healthy articular cartilage, chondrocytes maintain equilibrium
between degradation and synthesis. Injury, aging, and misuse can disturb
this balance triggering degeneration characteristic of osteoarthritis.
Current therapeutic options are limited. This study evaluated a novel
therapeutic that targets a cause of degradation, inﬂammatory cytokines
using a cartilage tissue analog (CTA). Using IL-1ra delivered by poly(lactic-
co-glycolic acid) (PLGA) microspheres (MS) our therapeutic approach
mitigates IL-1b’s deleterious effects on cartilage.
Methods: Microsphere Fabrication and Release Kinetics: PLGA MS were
fabricated using the water-oil-water double emulsion technique. Release
kinetics were determined in PBS under agitation at 37C. Over the course
of 5 weeks, supernatant was collected and IL-1ra content was quantiﬁed
using the bicinchoninic acid assay. Cell Isolation and CTA Fabrication:
Chondrocytes were isolated from juvenile bovine knees. Articular cartilage
was removed and minced, and digested with collagenase. The cell
suspension was ﬁltered and washed. Cells were seeded 1x107 cells/well
into a 96-well plate onto poly (2-hydroxyethyl methacrylate to maintain
their cartilage phenotype then cultured for 10 weeks. Cell Treatment: The
treatment groups were: untreated, 10 ng/ml IL-1b, and 10 ng/ml IL-1b +
500 mg/ml IL-1ra MS. CTAs were harvested after 3 and 6 days of treatment.
The 6-day treatment group included 60% media changes at 3 days, with
additional doses of IL-1b added to the relevant groups. mRNA Levels: RNA
was isolated from the CTAs via two sequential extractions using TRIZOL-
chloroform (n¼6). Reverse transcription was performed on 1 mg of RNA in
a 20 ml volume. Quantitative PCRwas performed to determinemRNA levels
of collagen II, aggrecan, COMP, IL-6, iNOS and ADAMTS4, and normalized to
GAPDH. Nitrite Concentration: Nitrite levels in the mediumwere measured
using the Griess assay. Statistics: Differences between treatment groups
were established using ANOVAs with post-hoc Tukey's tests; p<0.05 was
considered signiﬁcant.
Results: IL-1ra was released from the PLGAMS over the course of 5 weeks.
After a burst release in the ﬁrst hour (20.24.4ng per mg of MS), IL-1ra
release leveled to a linear release from day 2 to day 35 of 0.2 ng per mg of
MS per day (r2¼0.99). DeliveringMS to IL-1b treated CTAs inhibited IL-1b’s
effect. While IL-1b caused a large increase in nitrite concentration simul-
taneous IL-1raMS delivery reduced the increase. After both 3 and 6 days,
CTAs treated with IL-1b had signiﬁcantly higher iNOS, ADAMTS4, and IL-6
mRNA levels compared to untreated CTAs. IL-1b treated CTAs had a cor-
responding decrease in themRNA levels of collagen II, aggrecan and COMP.CTAs treated with both IL-1b and IL-1ra MS had no signiﬁcant differences
compared to the untreated.
ĂConclusions: In this study we showed for the ﬁrst time that sustained
IL1-ra released from PLGA microspheres can effectively inhibit IL-1b
mediated inﬂammation in cartilage. Our results suggest that this inhibition
was effective beyond the initial burst release, extending up to 6 days in the
presence of repeated doses of IL-1b. This study provides the foundation for
developing a novel treatment for osteoarthritis.
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FATTY ACIDS MODULATE DESTRUCTIVE AND INFLAMMATORY
PROCESSES IN OSTEOARTHRITIC CARTILAGE
M. Siawash. Erasmus Med. Ctr., Rotterdam, Netherlands
Purpose: Onset and progression of osteoarthritis (OA) are associated
with obesity. Since not only knee OA but also hand OA is associated with
obesity, it is plausible that next to increased joint loading, systemic
metabolic alterations such as adipose-related inﬂammation might
explain this association. In addition, obesity is correlated with altered
fatty acid proﬁles in serum. Recent studies indicate that n-3 poly
unsaturated fatty acids (PUFA's) such as eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) decrease inﬂammation and n-6 PUFA
arachidonic acid (AA) increases inﬂammation in OA joints. In this study
we aim to investigate whether other fatty acids known to be present in
the knee joint such as linoleic acid (n-6), oleic acid (n-9), and palmitic
acid (saturated) are also able to inﬂuence cartilage and thereby
contribute to processes seen in OA.
Methods: Cartilage was obtained from OA patients undergoing total knee
arthroplasty and either cultured as explants (3 donors) or as chon-
drocytes (2 donors) isolated from the cartilage (passage 3). All were
cultured in DMEM low glucose and 1% ITS with or without 10 ng/ml TNFa
as a pro-inﬂammatory stimulus and in absence or presence of DHA,
linoleic acid, oleic acid or palmitic acid. Concentrations were determined
using mass spectrometry. Analysis of cell cultures included quantiﬁcation
of intracellular lipid deposition using Oil-red-O, lactate hydrogenase
(LDH)-assay for cytotoxicity and gene expression for cyclooxygenase 2
(COX2), matrix metalloproteinase (MMP) 1, 3 and 13 and A Disintegrin
and Metalloproteinase with ThromboSpondin motifs (ADAMTS) 4. Carti-
lage explants were analysed for glycosaminoglycan (GAG) release and
nitric oxide (NO) production. Independent sample T-test was used for all
data analysis.
Results: Culturing chondrocytes in the presence of the fatty acids resulted
in an increase of intracellular lipid deposition as determined with Oil-red-
O staining. This effect was independent of TNFa presence in the culture
